Viewing Study NCT01239368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-01-31 @ 2:24 AM
Study NCT ID: NCT01239368
Status: TERMINATED
Last Update Posted: 2019-12-10
First Post: 2010-11-10
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloma, Plasma-Cell View
None Myeloma-Multiple View
None Myelomatosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None High Risk View
None Newly Diagnosed View
None Adoptive Immunotherapy View
None Autologous View